25 results on '"Marktel S"'
Search Results
2. Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation
3. Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors
4. BAT2 and BAT3 polymorphisms as novel genetic risk factors for rejection after HLA-related SCT
5. POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES) ASSOCIATED TO SIROLIMUS ADMINISTRATION: A CASE REPORT: PH-AB097
6. EXTRACORPOREAL PHOTOAFERESIS: AN EFFECTIVE TREATMENT FOR CUTANEOUS MANIFESTATIONS OF STEROID-DEPENDENT AND STEROID-REFRACTORY GVHD: PH-AB241
7. VERY LOW RATE OF RE-ADMISSION AFTER AN EARLY DISCHARGE OUTPATIENT MODEL FOR AUTOGRAFTING IN MULTIPLE MYELOMA PATIENTS: AN ITALIAN MULTI-CENTER RETROSPECTIVE STUDY: PH-P518
8. RAPID MOLECULAR DETECTION OF PATHOGENS IN 1941 BLOOD SAMPLES FROM 516 CONSECUTIVE PATIENTS WITH FEBRILE NEUTROPENIA: PH-P489
9. ACTIVE SURVEILLANCE AND PROMPT ANTIMICROBIAL THERAPY ALLOW REDUCING INFECTIOUS MORTALITY DUE TO CARBAPENEMASE-PRODUCING KLEBSIELLA SSP IN HEMATOPOIETIC STEM CELL TRANSPLANTATION: PH-P486
10. HUMAN HERPES VIRUS 6 AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: PH-P487
11. CLOFARABINE AND TREOSULFAN IN CONDITIONING FOR ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANT FROM MATCHED DONORS: A MULTICENTRIC PHASE II STUDY: PH-P103
12. T CELL DEPLETED HAPLOIDENTICAL STEM CELL TRANSPLANTATION FOLLOWED BY ADD-BACKS OF SUICIDE-GENE MODIFIED DONOR T-CELLS OFFERS LONG TERM SURVIVAL FREE OF IMMUNE SUPPRESSION TREATMENT: A 7 YEARS FOLLOW-UP IN 56 PATIENTS: PH-O084
13. Optimizing PBSC collection in working days: results of 121 patients undergoing chemotherapy plus G-CSF: R1481
14. Genotypes and haplotypes in the 3′ untranslated region of the HLA-G gene and their association with clinical outcome of hematopoietic stem cell transplantation for beta-thalassemia
15. JACIE accreditation path: the perspective of an Italian nurse: P1410
16. The nursing management of ADA-SCID children treated with gene therapy: P1343
17. Treosulfan-based conditioning regimen for allo-SCT in 283 patients: co-morbidity index and disease status are predictors of outcomes: P963
18. Favourable balance of allo-SCT at a long-term follow-up for patients with β-thalassaemia from countries with limited resources: P617
19. Risk of complications of haematopoietic stem cell collection in paediatric sibling donors: an EBMT Paediatric Diseases Working Party prospective observational study: O404
20. Escalating doses of donor lymphocytes for incipient graft rejection following SCT for thalassemia
21. Second hematopoietic SCT in patients with thalassemia recurrence following rejection of the first graft
22. Multiple BM harvests in pediatric donors for thalassemic siblings: safety, efficacy and ethical issues
23. Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacy
24. Management of chronic myeloid leukaemia in relapse following donor lymphocyte infusion induced remission: a retrospective study of the clinical trials committee of the British Society of Blood & Marrow Transplantation (BSBMT)
25. Prognostic factors for patients with chronic myeloid leukaemia in chronic phase treated with imatinib mesylate after failure of interferon alfa
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.